pegylated liposomal doxorubicin plus carboplatin
Topotecan plus carboplatin versus therapy with paclitaxel plus standard carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO- AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG study (HECTOR).
Topotecan plus carboplatin versus therapy with paclitaxel plus standard carboplatin ( PC ) or gemcitabine plus carboplatin ( GC ) or pegylated liposomal doxorubicin plus carboplatin ( PLDC ) : a randomized phase III trial of the NOGGO- AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG study ( HECTOR ) .